scispace - formally typeset
J

Jane Marjoribanks

Researcher at University of Auckland

Publications -  39
Citations -  4315

Jane Marjoribanks is an academic researcher from University of Auckland. The author has contributed to research in topics: Randomized controlled trial & In vitro fertilisation. The author has an hindex of 22, co-authored 39 publications receiving 3848 citations. Previous affiliations of Jane Marjoribanks include Cochrane Collaboration.

Papers
More filters
Journal ArticleDOI

Long term hormone therapy for perimenopausal and postmenopausal women

TL;DR: Assessment of effects of long-term HT on mortality, cardiovascular outcomes, cancer, gallbladder disease, fracture and cognition in perimenopausal and postmenopausal women during and after cessation of treatment found use of combined continuous HT significantly increased the risk of venous thromboembolism.
Journal ArticleDOI

Laparoscopic drilling by diathermy or laser for ovulation induction in anovulatory polycystic ovary syndrome

TL;DR: The effectiveness and safety of laparoscopic ovarian drilling compared with ovulation induction for subfertile women with clomiphene-resistant PCOS and the high heterogeneity in this subgroup could not be explained by population differences or differences in quality of the trials.
Journal ArticleDOI

Nonsteroidal anti‐inflammatory drugs for dysmenorrhoea

TL;DR: Among women with primary dysmenorrhoea, NSAIDs were more effective for pain relief than placebo, and there was little evidence of the superiority of any individual NSAID for either pain relief or safety.
Journal ArticleDOI

Number of embryos for transfer following in vitro fertilisation or intra‐cytoplasmic sperm injection

TL;DR: Evaluated randomised controlled trials comparing different policies for the number of embryos transferred following IVF or intra-cytoplasmic sperm injection in subfertile women found that for a woman with a 15% risk of multiple pregnancy following a single cycle of DET, the risk following asingle cycle of SET would be between 1% and 4%.
Journal ArticleDOI

Transvaginal mesh or grafts compared with native tissue repair for vaginal prolapse.

TL;DR: Awareness of prolapse at one to three years was less likely after mesh repair, and if 5% of women require repeat surgery after native tissue repair, between 7% and 18% in the permanent mesh group will do so, and effects on quality of life were uncertain.